Effects of Blatta orientalis on Treatment of Bronchial Asthma: A Prospective, Non-Randomised, Open-Label, Observational Study

Abstract

Background Bronchial asthma is a globally significant non-communicable disease with major public health consequences for both children and adults, including high morbidity, and relatively low mortality compared with other chronic diseases. It is a chronic disorder that compels the patient to take lifelong medications including bronchodilators.

Aim This study was undertaken to ascertain the effects of Blatta orientalis in centesimal potency on the treatment of bronchial asthma assessed by spirometry and Asthma Control Questionnaire (ACQ) Score.

Method A prospective, non-randomised, open-label, observational study was conducted at Dr. MPK Homoeopathic Medical College, Hospital & Research Centre, Jaipur, Rajasthan, from 2015 to 2016. Patients between 5 and 80 years of age suffering from dyspnoea, cough with expectoration and wheezing were screened. The convenience sampling technique was used to enrol 120 patients, after fulfilling the inclusion and exclusion criteria of the study. The patients of Bronchial asthma were treated with potentized Blatta orientalis for 6 months. Patients were diagnosed and assessed on the basis of the ACQ Score by Elizabeth Junipers and spirometry findings. Blatta orientalis was prescribed to all patients in increasing potency from 30C. The paired t-test was applied to calculate the statistical significance of the study.

Result Out of 120 patients, 100 had completed the study with follow-up of 6 months. A significant difference was found in pre- and post-treatment spirometry—that is, forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) ratio—from baseline to 6 months (mean ± standard deviation [SD]: –10.27 ± 4.95; 95% confidence interval [CI]: –11.25 to –9.28; p = 0.00001). Also, significant difference was seen in the ACQ Score from baseline to 6 months (mean ± SD: 19.44 ± 8.69; 95% CI: 17.71–21.16; p = 0.00001).

Conclusion The study findings are encouraging enough to prescribe Blatta orientalis in potency in cases of bronchial asthma. Further systematic replication is required. Conducted as randomised controlled trials with long-term follow-ups for definite conclusions.

Keywords

Bronchial asthma - Blatta orientalis - ACQ Score - Homoeopathy - Spirometry

Note

The trial protocol and full dissertation was submitted as a post-graduate thesis of the corresponding author.

Publication History

Article published online:
21 October 2020

• References

• 1 Tarraf H, Aydin O, Mungan D. et al. Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT program. BMC Pulm Med 2018; 18 (01) 68
• 2 Quirt J, Hildebrand KJ, Mazza J, Noya F, Kim H. Asthma. Allergy Asthma Clin Immunol 2018; 14 (Suppl. 02) 50
• 3 The Global Asthma Report 2018 [Internet]. Auckland, New Zealand: Global Asthma Network; 2018
• 4 Bhalla K, Nehra D, Nanda S, Verma R, Gupta A, Mehra S. Prevalence of bronchial asthma and its associated risk factors in school-going adolescents in Tier-III North Indian City. J Family Med Prim Care 2018; 7 (06) 1452-1457
• 5 Asthma Care Quick Reference: Diagnosing and Managing Asthma [Internet]. Bethesda, MD: U.S. Department of Health and Human Services. National Institutes of Health; [Revised Sep 2012]
• 6 Saglani S, Menzie-Gow AN. Approaches to asthma diagnosis in children and adults. Front Pediatr 2019; 7: 148
• 7 Shafei HF, AbdelDayem SM, Mohamed NH. Individualized homeopathy in a group of Egyptian asthmatic children. Homeopathy 2012; 101 (04) 224-230
• 8 Qutubuddin M, Singh SM, Nayak C, Koley M, Saha S. Efficacy of individualized homeopathy in bronchial asthma in adults: double-blind, randomized, placebo-controlled, clinical trial in the context of usual care. Adv Integr Med 2019; 6 (02) 58-65
• 9 Sharma B, Narula RH, Manchanda RK. Homoeopathy for the management of asthma-a review of Council's Clinical Research. Indian J Res Homoeopathy 2015; 9: 69-78
• 10 Ram H, Choudhary P, Kamboj M. Management of sub-acute exacerbation of bronchial asthma with Blatta orientalis: a case report. Homoeopathic Links. 2019; 32 (04) 256-261
• 11 Chandrakant Nimgulkar C, Dattatray Patil S, Dinesh Kumar B. Anti-asthmatic and anti-anaphylactic activities of Blatta orientalis mother tincture. Homeopathy 2011; 100 (03) 138-143
• 12 Boericke W. Boericke's New Manual of Homoeopathic Materia Medica with Repertory: Third Revised and Augmented Edition Based on Ninth Edition. New Delhi, India: B. Jain Publishers; 2010. . Blatta orientalis 213
• 13 Allen HC. Allen's Keynotes Rearranged and Classified with Leading Remedies of the Materia Medica and Bowel Nosodes. 10th Reprint Edition. New Delhi. India: B Jain Publishers; 2006
• 14 Kent JT. Repertory of the Homoeopathic Materia Medica. Reprinted from Sixth American Edition. New Delhi, India: B. Jain Publishers; 2009
• 15 Murphy R. Homoeopathic Medical Repertory. 2nd Revised Edition, Reprint Edition. New Delhi. India: B. Jain Publishers; 2004
• 16 Boger CM. Boenninghausen's Characteristics Materia Medica and Repertory with Corrected and Revised Abbreviation and Word Index. New Delhi. India: B. Jain Publishers; 2010
• 17 Vithoulkas G. Materia Medica Viva. 5th volume. Belgium: The International Academy of Classical Homoeopathy; 2010. . Blatta orientalis 587-588
• 18 Verma PN. Vaid Indu. Encyclopaedia of Homoeopathic Pharmacopoeia and Drug Index. 1st volume. 4th updated edition. New Delhi. India: B. Jain Publishers; 2007
• 19 Clarke JH. A Dictionary of Practical Materia Medica. 1st volume. 1st edition. New Delhi. India: B. Jain Publishers; 2005
• 20 Ethical principles for medical research involving human subjects. World Medical Association Declaration of Helsinki. 48th WMA General Assembly, Somerset West, Republic of South Africa. Accessed June 9, 2020 at: http://www.wma.net/en/30publications
• 21 Good clinical practices for clinical research in India. Central Drugs Standard Control Organization, Dte. GHS, Ministry of Health and Family Welfare, Government of India. 2013. Available at: www.sgpgi.ac.in/sop/GCP-Indian/pdf
• 22 Global Initiative for Asthma. Global strategy for asthma management and prevention. 2019 . Accessed June 9, 2020 at: www.ginasthma.org
• 23 Juniper EF, O'Byrne PM, Ferrie PJ, King DR, Roberts JN. Measuring asthma control. Clinic questionnaire or daily diary?. Am J Respir Crit Care Med 2000; 162 (4 Pt 1): 1330-1334
• 24 BC Cancer Care and Research Agency. Symptoms management guidelines: dyspnoea. Dyspnoea Grading Scale. National Cancer Institute CTCAE (Version 4.03). Available at: http://www.bccancer.bc.ca/nursingsite/Documents/Symptom%20Management%20Guidelines/4Dyspnea1.pdf
• 25 Bateman ED, Hurd SS, Barnes PJ. et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31 (01) 143-178
• 26 Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000; 106 (05) S201-S205
• 27 Singh H, Katara S. Study of 413 cases of bronchial asthma treated with homoeopathic system of medicine. CCRH Bulletin. 1992; 13 (3&4): 5-11